Skip to Main Content

Paper Details

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Clin Cancer Res
1
2023
11q13 genes, AR, ATM, ATM Mutations, ATM and, ATM-, ATM- and BRCA2-mutated tumors, ATM-mutated mPCs, ATM-mutated tumors, BRCA2, BRCA2 mutations, BRCA2-mutated mPCs, BRCA2-mutated tumors, CCND1, FGF family, HRDother, HRP, HRR, HRR mutations, HRR-deficient, Metastatic, Metastatic Prostate Cancers, PARPi, TP53, cell-cycle genes, homologous recombination repair, homologous recombination repair (HRR) genes, mPC, mPCs, metastatic prostate cancer, microsatellite, microsatellite-instable (MSI) tumors, patients, taxane
Author NameAffiliation
Joanne Xiu
Elisabeth I HeathKarmanos Cancer Institute
Emmanuel S AntonarakisMasonic Cancer Center, University of Minnesota-Twin Cities
Emmanuel S AntonarakisUniversity of Minnesota-Twin Cities
  • 1 - 4

Datasets

Release 1.2